Sinergium Biotech: an innovative production model
Protein Sciences Zika Vaccine Shows Good Results in Preclinical Testing
Sinergium Biotech is an Argentine pharmaceutical company specialized in the research, development, production and marketing of vaccines and highly complex biotechnology products.
Protein Sciences Corporation, a leading vaccine development company and maker of Flublok Influenza Vaccine®, announced today that its lead protein based Zika vaccine candidate had good safety results and induced strong neutralizing antibodies against the Zika virus in preclinical studies.
September 11, 2016
January 23, 2017
April 14, 2016